Shenzhen Edge Medical Co., Ltd. (HKG:2675)

Market Cap	12.10B
Revenue (ttm)	722.29M +124.1%
Net Income	-21.67M
EPS	-0.06
Shares Out	389.62M
PE Ratio	n/a
Forward PE	76.74
Dividend	n/a
Ex-Dividend Date	n/a

Volume	558,700
Open	31.68
Previous Close	31.68
Day's Range	30.58 - 32.68
52-Week Range	29.78 - 73.70
Beta	n/a
Analysts	Strong Buy
Price Target	56.87 (+83.1%)
Est. Earnings	Nov 27, 2026

About Shenzhen Edge Medical

Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. The company focus on surgical robots and instruments for minimally invasive surgery or MIS, including multi-port endoscopic surgical robots and single-port endoscopic surgical robots. Its products include Edge Multi-Port Endoscopic Surgical Robot, a robot-assisted device that is applied to perform MIS using robotic, imaging, and digital technologies; Edge Single-Port Endoscopic Surgical Robot, a robot-assisted devic...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Employees: 604
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2675

Financial Performance

In 2025, Shenzhen Edge Medical's revenue was 455.72 million, an increase of 184.83% compared to the previous year's 159.99 million. Losses were -88.61 million, -59.45% less than in 2024.

Financial numbers in CNY

Analyst Summary

According to 5 analysts, the average rating for 2675 stock is "Strong Buy." The 12-month stock price target is $56.87, which is an increase of 83.10% from the latest price.

Price Target

$56.87

(83.10% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error